XU Peng, BIAN Xinghua, WANG Yuhang. Effects of adipokines, inflammatory factors and intestinal flora on major adverse cardiovascular events in patients with coronary heart disease after percutaneous coronary intervention[J]. Journal of Clinical Medicine in Practice, 2023, 27(13): 81-86. DOI: 10.7619/jcmp.20231409
Citation: XU Peng, BIAN Xinghua, WANG Yuhang. Effects of adipokines, inflammatory factors and intestinal flora on major adverse cardiovascular events in patients with coronary heart disease after percutaneous coronary intervention[J]. Journal of Clinical Medicine in Practice, 2023, 27(13): 81-86. DOI: 10.7619/jcmp.20231409

Effects of adipokines, inflammatory factors and intestinal flora on major adverse cardiovascular events in patients with coronary heart disease after percutaneous coronary intervention

More Information
  • Received Date: May 03, 2023
  • Revised Date: June 19, 2023
  • Available Online: July 18, 2023
  • Objective 

    To investigate the effects of serum adipokines, inflammatory factors and intestinal flora on major adverse cardiovascular events (MACE) in patients with coronary heart disease after percutaneous coronary intervention (PCI).

    Methods 

    A total of 120 coronary heart disease patients with PCI were selected as study group, and 60 healthy individuals with routine health examination in the same period were selected as control group. The differences in serum adipokines [adipocyte fatty acid binding protein (AFABP), visceral fat tissue-derived serine protease inhibitor (Vaspin), Apelin], inflammatory factors[interleukin-6 (IL-6), high mobility group box 1 (HMGB1), high-sensitivity C reactive protein (hs-CRP)] and intestinal flora were compared between the two groups. The differences in serum adipokines, inflammatory factors and intestinal flora among patients with different types of coronary heart disease[stable angina pectoris (SAP) in 41 cases, unstable angina pectoris (UAP) in 37 cases, and acute myocardial infarction (AMI) in 42 cases] were analyzed. The correlations of inflammatory factors with serum adipokines and intestinal flora were analyzed. The occurrence of MACE was recorded during a year of follow-up in the study group, and the influencing factors of MACE were analyzed.

    Results 

    The levels of AFABP, IL-6, HMGB1 and hs-CRP in the study group were significantly higher than those in the control group, while the levels of Vaspin, Apelin, Lactobacillus, Bifidobacterium and Escherichia coli were significantly lower than those in the control group (P < 0.05). The levels of Vaspin in the UAP group and AMI group were significantly lower than that in the SAP group, while the levels of IL-6, HMGB1 and hs-CRP in the AMI group were significantly higher than those in the UAP group and SAP group (P < 0.05). Pearson correlation analysis showed that IL-6, HMGB1 and hs-CRP were positively correlated with AFABP (P < 0.05), while IL-6, HMGB1 and hs-CRP were negatively correlated with Vaspin, Apelin, Lactobacillus, Bifidobacterium and Escherichia coli (P < 0.05). Binary Logistic regression analysis showed that age over 80 years, AMI, diabetes, hypertension, the number of implanted stents≥3, AFABP, IL-6, HMGB1 and hs-CRP were risk factors for the occurrence of MACE, while Vaspin, Apelin, Lactobacillus, Bifidobacterium and Escherichia coli were the protective factors for the occurrence of MACE (P < 0.05).

    Conclusion 

    Patients with coronary heart disease have abnormal expression of serum adipokines, inflammatory factors and intestinal flora after PCI, and there are differences among patients with different types of coronary heart disease. Inflammatory factors are correlated with serum adipokines and intestinal flora. Age, type of coronary heart disease, diabetes, hypertension, the number of implanted stents, adipokines and inflammatory factors as well as intestinal flora indicators are the independent risk factors for the occurrence of MACE after surgery.

  • [1]
    ONO M, SERRUYS P W, HARA H, et al. 10-year follow-up after revascularization in elderly patients with complex coronary artery disease[J]. J Am Coll Cardiol, 2021, 77(22): 2761-2773. doi: 10.1016/j.jacc.2021.04.016
    [2]
    WILLIAMS M C, KWIECINSKI J, DORIS M, et al. Low-attenuation noncalcified plaque on coronary computed tomography angiography predicts myocardial infarction: results from the multicenter SCOT-HEART trial (scottish computed tomography of the HEART)[J]. Circulation, 2020, 141(18): 1452-1462. doi: 10.1161/CIRCULATIONAHA.119.044720
    [3]
    张珂瑞, 李勇. 冠心病患者经皮冠状动脉介入术后支架内再狭窄危险因素的研究进展[J]. 医学综述, 2022, 28(1): 105-111. https://www.cnki.com.cn/Article/CJFDTOTAL-YXZS202201019.htm
    [4]
    STONE G W, MAEHARA A, ALI Z A, et al. Percutaneous coronary intervention for vulnerable coronary atherosclerotic plaque[J]. J Am Coll Cardiol, 2020, 76(20): 2289-2301. doi: 10.1016/j.jacc.2020.09.547
    [5]
    高洁, 易蔚, 吕珊珊, 等. 血清心型脂肪酸结合蛋白、游离脂肪酸对老年冠心病患者经皮冠状动脉介入术后心肌损伤的诊断价值[J]. 实用临床医药杂志, 2021, 25(21): 28-32. doi: 10.7619/jcmp.20212194
    [6]
    李洋洋, 梁力晖, 陈柏林, 等. 急性冠脉综合征患者经皮冠状动脉介入术后院内MACE发作风险预测模型构建[J]. 心脏杂志, 2022, 34(5): 531-536. https://www.cnki.com.cn/Article/CJFDTOTAL-XGNZ202205007.htm
    [7]
    MARON D J, HOCHMAN J S, REYNOLDS H R, et al. Initial invasive or conservative strategy for stable coronary disease[J]. N Engl J Med, 2020, 382(15): 1395-1407. doi: 10.1056/NEJMoa1915922
    [8]
    PATTERSON T, CLAYTON T, DODD M, et al. ACTIVATION (PercutAneous coronary inTervention prIor to transcatheter aortic VAlve implantaTION): a randomized clinical trial[J]. JACC Cardiovasc Interv, 2021, 14(18): 1965-1974. doi: 10.1016/j.jcin.2021.06.041
    [9]
    高荣华, 陈雪英, 张韶辉, 等. 血清脂肪因子vaspin、apelin对ACS患者PCI术后心血管终点事件发生的预测价值[J]. 中国循证心血管医学杂志, 2021, 13(8): 1003-1006. https://www.cnki.com.cn/Article/CJFDTOTAL-PZXX202108026.htm
    [10]
    李文俊, 杨云红, 谢灵芝, 等. 冠心病与肠道菌群的相关性研究[J]. 重庆医科大学学报, 2021, 46(2): 146-150. https://www.cnki.com.cn/Article/CJFDTOTAL-ZQYK202102005.htm
    [11]
    张萌, 李彦红. 心力衰竭患者血浆Vaspin的表达及其临床意义[J]. 临床心血管病杂志, 2022, 38(2): 141-145. https://www.cnki.com.cn/Article/CJFDTOTAL-LCXB202202012.htm
    [12]
    陈宗洋, 钱福东, 储岳峰, 等. 外周血炎性指标与甲状腺激素水平对急性心肌梗死患者合并心力衰竭的诊断价值[J]. 广西医学, 2022, 44(17): 1955-1960. https://www.cnki.com.cn/Article/CJFDTOTAL-GYYX202217003.htm
    [13]
    伍星, 刘波, 杨秋. 冠心病患者糖脂代谢与肠道菌群平衡的关系[J]. 中国微生态学杂志, 2022, 34(8): 921-925. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWS202208009.htm
    [14]
    史玛诺, 冯珊珊, 于源. 高龄冠心病患者PCI术后发生MACE的影响因素[J]. 心血管康复医学杂志, 2022, 31(6): 688-692. https://www.cnki.com.cn/Article/CJFDTOTAL-XXGK202206007.htm
    [15]
    樊明媛, 李雪萍, 芮思艳, 等. 冠心病PCI支架植入术后1年再入院的中医证素分布规律及相关危险因素分析[J]. 中西医结合心脑血管病杂志, 2022, 20(15): 2783-2787. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYY202215017.htm
  • Cited by

    Periodical cited type(1)

    1. 诸建华. 富血小板纤维蛋白治疗慢性创面的应用价值探讨. 中国实用乡村医生杂志. 2024(08): 72-74+78 .

    Other cited types(0)

Catalog

    Article views PDF downloads Cited by(1)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return